Ciambra

Medicinal product

(Invented) name

Ciambra

Active substance (s)

Pemetreksedas

Strength

500 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

L01BA04, Pemetrexed

Marketing authorisation holder

Menarini International Operations Luxembourg S.A., Liuksemburgas

Date of authorisation

2015-12-02

Date of renewal

Documents

Stage

Išregistruotas

Controlled?

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for concentrate for solution for infusion	1 vnt.
Pemetreksedas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
64612	79096	1079096	flakonas	N1		Receptinis	EU/1/15/1055/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-12-01	Išregistruotas
2015-12-02	Registruotas